Diabetic Kidney Disease

Using DNA methylation markers in blood samples may help predict the progression of diabetic kidney disease in patients with type 2 diabetes, recent data suggests.

Asian adults with diabetes and normal kidney function have a higher risk for albuminuria than non-Hispanic white adults, but the risk varies among ethnic subgroups, according to a brief report published in Diabetes Care.

Among patients with type 2 diabetes and chronic kidney disease, finerenone treatment may provide cardiovascular benefits, according to data published in the Clinical Journal of the American Society of Nephrology.

Adults with type 2 diabetes have a higher risk for diabetic foot ulcers if they have albuminuric diabetic kidney disease, but not if they have normal albumin levels, according to study findings.

Among patients with diabetic kidney disease, intrarenal podocalyxin level was an independent predictor of dialysis-free survival, according to data published in Kidney Medicine.

The Centers for Medicare and Medicaid Innovation launched the Kidney Care Choices model to pay nephrologists and their practice teams to treat patients with stage 4 and 5 chronic kidney disease.

Best diabetes medical treatment was just as effective in albuminuria remission as Roux-en-Y gastric bypass for adults with diabetic kidney disease and obesity, according to study results published in eClinical Medicine.

The American Diabetes Association and Kidney Disease: Improving Global Outcomes have released a consensus report addressing diabetes management in chronic kidney disease.

PHILADELPHIA — Chronic kidney disease assessment and monitoring by albuminuria and estimated glomerular filtration rate is necessary for delivering goal-directed therapies to people with diabetes, according to a speaker.

The Kidney Research Institute has named Ian de Boer, MD, MS, as its new director following the 14-year run of its founding director, Jonathan Himmelfarb, MD.